Screenshot+2018-12-14+16.31.23.jpg

our science

NAD+ is critically important to the function of all living cells. NAD+ levels have been shown to decline as humans age and research and preclinical models have demonstrated the broad therapeutic potential of increasing NAD+ to preserve health and normal metabolism.

bauhaus-bars-01.png
 
crystals-image001.jpg

OUR pipeline

Metro International Biotech boasts a novel drug development platform, producing first-in-class, small-molecule NAD+ enhancers that leverage the NAD+ cycle to treat rare diseases and pursue significant improvements in human health to combat the adverse conditions of aging. Metro International Biotech is initially targeting rare mitochondrial diseases.

 
bauhaus-bars-03.png
 
5713_medical-journals-and-publishing.png

publications

Recent discoveries published in leading scientific and medical journals highlight the broad therapeutic potential of modulating NAD+ to treat a range of conditions.